Tag: Cellectis SA

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cellectis SA

Goldman Sachs Group Reiterates “$20.00” Price Target for Cellectis (NASDAQ:CLLS)

Added to Collection on: 2019-08-22 19:48:45

Tags for this article:

Money
Finance
Hedge fund
Economy
Short
Financial analyst
Securities research
Cellectis
Cellectis SA

Click the tags to see associated articles and topics

View Article Details
Cellectis SA (NASDAQ:CLLS) Stake Lifted by ARK Investment Management LLC

Added to Collection on: 2019-08-25 15:30:00

Tags for this article:

Money
Finance
Economy
Stock market
Stock
Short
Financial analyst
Securities research
Cellectis
Cellectis SA
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Cellectis SA (NASDAQ:CLLS) Stake Increased by Sumitomo Mitsui Trust Holdings Inc.

Added to Collection on: 2019-08-29 18:18:45

Tags for this article:

Money
Finance
Economy
Stock
Short
Securities research
Sumitomo Mitsui Trust Holdings
Cellectis
Cellectis SA

Click the tags to see associated articles and topics

View Article Details
Goldman Sachs Group Analysts Give Cellectis (NASDAQ:CLLS) a $20.00 Price Target

Added to Collection on: 2019-08-29 14:21:22

Tags for this article:

Money
Finance
Hedge fund
Economy
Short
Goldman Sachs
Securities research
Cellectis
Cellectis SA
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Lowers Stock Holdings in Cellectis SA (NASDAQ:CLLS)

Added to Collection on: 2019-12-21 19:48:45

Tags for this article:

Finance
Money
Cellectis
Economy
Alternative investment management companies
Hedge fund
Financial analyst
Cellectis SA

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial ...

Added to Collection on: 2020-12-02 12:33:45

Tags for this article:

Companies
Life Sciences
Pharmaceutical companies
Medical research
Economy of New York City
NASDAQ
Pfizer
Moderna
Cellectis
BioNTech
BeiGene
Cerevel Therapeutics Holdings Inc
ARGENX SE
Codiak BioSciences Inc
Auris Medical Holding Ltd
Arcturus Therapeutics Holdings Inc.
Bicycle Therapeutics plc
CRISPR Therapeutics AG
Atara Biotherapeutics Inc.
BioTelemetry Inc.
Cardiff Oncology Inc.
AbbVie Inc.
Blueprint Medicines Corp
BridgeBio Pharma Inc
Eidos Therapeutics Inc
Cellectis SA
Bioanalytical Systems, Inc

Click the tags to see associated articles and topics

View Article Details
Prosight Management, LP Buys Galapagos NV, Kezar Life Sciences Inc, Oscar Health Inc, Sells ...

Added to Collection on: 2021-05-14 21:33:45

Tags for this article:

Financial economics
Finance
Financial markets
Specialty drugs
Corporate finance
Stock
Stock market
Alexion Pharmaceuticals
Alexion Pharmaceuticals Inc.
Cigna Corp.
Oscar Health Inc.
Medtronic PLC
Organogenesis Holdings Inc
Change Healthcare Inc.
Cellectis SA
Kezar Life Sciences Inc
Baxter International Inc.
Galapagos NV

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
Cellectis S.A. (NASDAQ:CLLS) short interest falls by 28.2%. - Best Stocks

Added to Collection on: 2022-12-17 14:12:06

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Cellectis
Short
Stock
Share
Cellectis SA

Click the tags to see associated articles and topics

View Article Details
Cellectis Pioneers Non-Viral Gene Therapy for SCD - TipRanks.com

Added to Collection on: 2024-06-12 21:04:50

Tags for this article:

Hemoglobins
Molecular biology
Genetic engineering
Biotechnology
Cellectis
Sickle-cell disease
Gene therapy
Hemoglobin subunit beta
Stearoyl-CoA 9-desaturase
Transcription activator-like effector nuclease
Cellectis SA

Click the tags to see associated articles and topics

View Article Details